Is Philip Morris Stock Overvalued?
If there is one industry that can be termed truly…
Sell
33
NURAF Quote, Financials, Valuation and Earnings
Last price:
$30.15
Seasonality move
:
-8.31%
Day range:
$28.57 - $32.18
52-week range:
$23.93 - $39.15
Dividend yield:
1.3%
P/E ratio:
30.54x
P/S ratio:
3.47x
P/B ratio:
6.06x
Volume:
21.8K
Avg. volume:
20.4K
1-year change:
1.34%
Market cap:
$17.2B
Revenue:
$5.1B
EPS (TTM):
$0.98
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nomura Research Institute has -- downside to fair value with a price target of -- per share.
NURAF vs. S&P 500
-
Over the past 5 trading days, Nomura Research Institute has underperformed the S&P 500 by -3.47% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nomura Research Institute does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nomura Research Institute revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Nomura Research Institute reported revenues of $1.2B.
Earnings Growth
-
Nomura Research Institute has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Nomura Research Institute reported earnings per share of $0.25.
Enterprise value:
17.8B
EV / Invested capital:
--
Price / LTM sales:
3.47x
EV / EBIT:
20.48x
EV / Revenue:
3.55x
PEG ratio (5yr expected):
4.78x
EV / Free cash flow:
27.82x
Price / Operating cash flow:
22.61x
Enterprise value / EBITDA:
14.89x
Gross Profit (TTM):
$1.8B
Return On Assets:
9.54%
Net Income Margin (TTM):
11.3%
Return On Equity:
20.13%
Return On Invested Capital:
13.04%
Operating Margin:
17.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $5.4B | $5.1B | $5B | $1.3B | $1.2B | |
| Gross Profit | $1.9B | $1.8B | $1.8B | $460.4M | $434M | |
| Operating Income | $918.3M | $804.6M | $840.3M | $195.9M | $208.4M | |
| EBITDA | $1.3B | $1.2B | $1.2B | $289.9M | $296.8M | |
| Diluted EPS | $1.04 | $0.92 | $0.98 | $0.21 | $0.25 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.6B | $2.9B | $2.3B | $2.3B | $2.7B | |
| Total Assets | $5.2B | $6.2B | $5.6B | $5.8B | $6.3B | |
| Current Liabilities | $1.5B | $2.4B | $2B | $1.4B | $1.4B | |
| Total Liabilities | $2.4B | $3.5B | $3B | $3.2B | $3.4B | |
| Total Equity | $2.9B | $2.7B | $2.6B | $2.6B | $2.9B | |
| Total Debt | $1.1B | $1.5B | $1.4B | $1.6B | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $874.2M | $880.5M | $986M | $337.7M | $310.5M | |
| Cash From Investing | -$1.2B | -$453.1M | -$370.2M | -$127.7M | -$78.2M | |
| Cash From Financing | -$71.2M | -$332.7M | -$329.7M | -$437.1M | -$34.5M | |
| Free Cash Flow | $491.3M | $475.4M | $640.9M | $216.6M | $233.9M | |
NURAF
Sector
Market Cap
$17.2B
$117.2M
Price % of 52-Week High
77.01%
68.86%
Dividend Yield
1.3%
0%
Shareholder Yield
5.85%
0.91%
1-Year Price Total Return
1.35%
-3.38%
Beta (5-Year)
--
0.915
Dividend yield:
1.3%
Annualized payout:
$0.35
Payout ratio:
16.12%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$29.49
200-day SMA
Sell
Level
$30.18
Bollinger Bands (100)
Sell
Level
29.27 - 35.03
Chaikin Money Flow
Sell
Level
-239.6K
20-day SMA
Buy
Level
$29.52
Relative Strength Index (RSI14)
Buy
Level
52.71
ADX Line
Buy
Level
28.29
Williams %R
Neutral
Level
-39.6098
50-day SMA
Buy
Level
$29.74
MACD (12, 26)
Sell
Level
-0.18
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
780.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.8951)
Buy
CA Score
(Annual)
Level (0.2758)
Buy
Beneish M-Score
(Annual)
Level (-2.9304)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.749)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nomura Research Institute Ltd provides Consulting, Financial IT solutions, Industrial IT solutions and IT platform services. Its consulting service includes management and systems consulting. Financial IT solutions consists of securities, banking and insurance business. Industrial IT solutions cover distribution and healthcare business and manufacturing and service industries. IT platform services include IT infrastructure, System management and advanced information technology solutions.
Stock Forecast FAQ
In the current month, NURAF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NURAF average analyst price target in the past 3 months is --.
-
Where Will Nomura Research Institute Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nomura Research Institute share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Nomura Research Institute?
Analysts are divided on their view about Nomura Research Institute share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nomura Research Institute is a Sell and believe this share price will rise from its current level to --.
-
What Is Nomura Research Institute's Price Target?
The price target for Nomura Research Institute over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NURAF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nomura Research Institute is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NURAF?
You can purchase shares of Nomura Research Institute via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nomura Research Institute shares.
-
What Is The Nomura Research Institute Share Price Today?
Nomura Research Institute was last trading at $30.15 per share. This represents the most recent stock quote for Nomura Research Institute. Yesterday, Nomura Research Institute closed at $30.15 per share.
-
How To Buy Nomura Research Institute Stock Online?
In order to purchase Nomura Research Institute stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Quantum Stocks Should I Buy?
The last several years have seen a series of tech…
Will Sirius XM Be a 10-Bagger Stock?
Last year, Warren Buffett surprised practically everyone when he acquired…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
49
RKLB alert for Jan 22
Rocket Lab USA [RKLB] is up 30.42% over the past day.
Sell
32
FTAI alert for Jan 22
FTAI Aviation [FTAI] is down 25.44% over the past day.
Sell
2
EDU alert for Jan 22
New Oriental Education & Technology Group [EDU] is down 23.18% over the past day.
